The present study is an attempt to test the expression of CDKN2B-AS1, CDKN2B and CDKN2A/ARF in TM cells, which are one of the primary cells affected in POAG, and to correlate their functions with downstream pathway regulation. The gene discussed is CDKN2A; the disease is open-angle glaucoma.